We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
(+1,256%)
Cap. Flow
+$230B
Cap. Flow
% of AUM
90.52%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.24B |
| 2 |
Apple
AAPL
|
+$6.76B |
| 3 |
Amazon
AMZN
|
+$6.52B |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$3.45B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$142M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$40.1M |
| 3 |
Nuveen ESG Large-Cap Value ETF
NULV
|
+$22M |
| 4 |
Nuveen ESG Small-Cap ETF
NUSC
|
+$20.8M |
| 5 |
Nuveen ESG Large-Cap Growth ETF
NULG
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.97% |
| 2 | Financials | 14.46% |
| 3 | Healthcare | 12.78% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Amneal Pharmaceuticals
AMRX
$5.79B
| $2.5M | ﹤0.01% |
+349,348
| New | +$3.57M |
|
|
ACBI
2327
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $2.5M | ﹤0.01% |
+146,245
| New | +$2.55M |
|
|
FFG
2328
DELISTED
FBL Financial Group
FFG
| $2.5M | ﹤0.01% |
+39,164
| New | +$2.5M |
|
|
OMN
2329
DELISTED
OMNOVA Solutions Inc.
OMN
| $2.49M | ﹤0.01% |
+399,960
| New | +$2.67M |
|
2330
Funko
FNKO
$328M
| $2.49M | ﹤0.01% |
+102,867
| New | +$2.19M |
|
|
PFC
2331
DELISTED
Premier Financial Corp. Common Stock
PFC
| $2.49M | ﹤0.01% |
+87,170
| New | +$2.5M |
|
|
BRY
2332
DELISTED
Berry Corp
BRY
| $2.48M | ﹤0.01% |
+234,035
| New | +$2.65M |
|
|
STFC
2333
DELISTED
State Auto Financial Corp
STFC
| $2.48M | ﹤0.01% |
+70,801
| New | +$2.4M |
|
2334
WPP
WPP
$5.94B
| $2.48M | ﹤0.01% |
39,367
+31,741
| +416% | +$1.92M |
|
2335
Bally's
BALY
$658M
| $2.47M | ﹤0.01% |
+83,032
| New | +$2.59M |
|
2336
ATN International
ATNI
$492M
| $2.46M | ﹤0.01% |
+42,666
| New | +$2.56M |
|
2337
Resources Connection
RGP
$145M
| $2.46M | ﹤0.01% |
+153,804
| New | +$2.45M |
|
|
CBAY
2338
DELISTED
Cymabay Therapeutics
CBAY
| $2.46M | ﹤0.01% |
+344,046
| New | +$3.9M |
|
2339
Weis Markets
WMK
$1.86B
| $2.46M | ﹤0.01% |
+67,472
| New | +$2.65M |
|
|
LDL
2340
DELISTED
Lydall, Inc.
LDL
| $2.46M | ﹤0.01% |
+121,562
| New | +$2.65M |
|
|
EGRX
2341
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.45M | ﹤0.01% |
+44,068
| New | +$2.3M |
|
|
TBRG
2342
DELISTED
TruBridge
TBRG
| $2.44M | ﹤0.01% |
+87,671
| New | +$2.45M |
|
2343
Lennar Class B
LEN.B
$20.8B
| $2.44M | ﹤0.01% |
+66,511
| New | +$2.6M |
|
|
GTT
2344
DELISTED
GTT Communications, Inc.
GTT
| $2.42M | ﹤0.01% |
+137,425
| New | +$4.25M |
|
2345
Intellia Therapeutics
NTLA
$1.67B
| $2.42M | ﹤0.01% |
+147,585
| New | +$2.32M |
|
2346
Smith & Wesson
SWBI
$637M
| $2.4M | ﹤0.01% |
+346,233
| New | +$2.45M |
|
|
NPTN
2347
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.4M | ﹤0.01% |
+573,621
| New | +$3.02M |
|
2348
Precigen
PGEN
$2.59B
| $2.39M | ﹤0.01% |
+312,350
| New | +$1.68M |
|
|
DF
2349
DELISTED
Dean Foods Company
DF
| $2.39M | ﹤0.01% |
+2,586,034
| New | +$4.16M |
|
|
JMIA
2350
Jumia Technologies
JMIA
$767M
| $2.38M | ﹤0.01% |
+89,958
| New | +$2.59M |
|
Similar funds
VFT
Nuveen's Q2 2019 Portfolio in Review
As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.
- Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
- Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
- Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
- Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
- Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
- Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
- Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.
Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.